2024
DOI: 10.1002/nav.22181
|View full text |Cite
|
Sign up to set email alerts
|

Optimization modeling for pandemic vaccine supply chain management: A review and future research opportunities

Shibshankar Dey,
Ali Kaan Kurbanzade,
Esma S. Gel
et al.

Abstract: During various stages of the COVID‐19 pandemic, countries implemented diverse vaccine management approaches, influenced by variations in infrastructure and socio‐economic conditions. This article provides a comprehensive overview of optimization models developed by the research community throughout the COVID‐19 era, aimed at enhancing vaccine distribution and establishing a standardized framework for future pandemic preparedness. These models address critical issues such as site selection, inventory management… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 120 publications
0
1
0
Order By: Relevance
“…COVID-19 model predictions were discussed on national news networks and in US White House press briefings (9,10). Indeed, scenario modeling of SARS-CoV-2 dynamics was critical in helping state and federal governments explore and enact large-scale interventions, such as shelter-in-place orders, to combat transmission and avert overwhelmed hospital systems (3,(11)(12)(13), and models were also used to address the optimal allocation of vaccines when they became available (14).…”
Section: Introductionmentioning
confidence: 99%
“…COVID-19 model predictions were discussed on national news networks and in US White House press briefings (9,10). Indeed, scenario modeling of SARS-CoV-2 dynamics was critical in helping state and federal governments explore and enact large-scale interventions, such as shelter-in-place orders, to combat transmission and avert overwhelmed hospital systems (3,(11)(12)(13), and models were also used to address the optimal allocation of vaccines when they became available (14).…”
Section: Introductionmentioning
confidence: 99%